Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIT | P10721 | 4/20 | 0.32 |
| ▸ | MAP3K8 | P41279 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.30 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3846696 | 0.85 | KIT (0.35) | KITPDPK1CSNK1DCSNK1E | |
| SCHEMBL3847768 | 0.84 | MAP4K4 (0.32) | KITPIK3CDPIK3CAPIK3CBMTOR | |
| SCHEMBL4716874 | 0.84 | CYP3A4 (0.33) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL3846535 | 0.84 | PIK3CD (0.32) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL3847727 | 0.84 | PIK3CD (0.41) | KITCSNK1DCSNK1EPIK3CDPIK3CA | |
| SCHEMBL3854489 | 0.83 | PTGS2 (0.35) | KITPDPK1PIK3CDPIK3CAPIK3CB | |
| SCHEMBL3852824 | 0.83 | KDM4E (0.33) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL3845563 | 0.82 | EGFR (0.33) | PIK3CDPIK3CAPIK3CBMTORPIK3CG | |
| SCHEMBL3846935 | 0.82 | KIT (0.34) | KITMAP3K8PDPK1PIK3CDPIK3CA | |
| SCHEMBL3851042 | 0.82 | CYP1A2 (0.35) | PIK3CDPIK3CAPIK3CBMTORPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |